Delivery Order SPE2DR25D1022-SPE2DR26FQR8A
Award Date 12/9/25
Potential Completion Date 12/10/25
Potential Value $14K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency (DLA) on September 18, 2025, for XCOPRI 100 mg tablets (30-count units) with a ceiling value of $2,866.68. This competitively awarded, firm fixed-price contract is scheduled for completion by September 19, 2025, with performance taking place at the vendor's Conshohocken facility. The award carries no set-aside...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,396.12 to AmerisourceBergen Drug Corp for the supply of Xcopri 50 mg tablets (30-count units). This competitively awarded, firm fixed price delivery order was issued on August 18, 2025, with an ultimate completion date of August 19, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a discrete transaction under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,282.76 for XCOPRI 50 mg tablets (30-count supply) on December 5, 2025, with completion scheduled for December 8, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a leading pharmaceutical distributor...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,916.59 to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Xcopri 50 mg tablets (30-count packaging). This firm fixed-price delivery order, which is not a set-aside contract, represents a competitive award under DLA's broader pharmaceutical procurement framework. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of December 9,...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order contract by the Defense Logistics Agency (DLA) for the supply of Xcopri 100 mg tablets (30-count units) with a ceiling value of $5,136.21. The contract was awarded on November 24, 2025, with an ultimate completion date of November 25, 2025, utilizing firm fixed-price pricing with no set-aside designation. This delivery order represents a competitive award issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Xcopri 100 mg tablets (30-count packaging) with a ceiling value of $1,178.96. This firm fixed-price delivery order, which is not set-aside, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The order will be fulfilled from the...
- Amerisourcebergen Drug Corporation, operating as Amerisourcebergen, has been awarded a $1,624 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to supply 50mg Xcopri tablets. The single delivery order is for 30 tablets and will be fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania over one day in September 2023. No additional details were provided on the original solicitation or whether this delivery order is associated with any...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on July 21, 2025, for the supply of Fycompa 2 mg tablets (30-count units) valued at $1,493.69. This competitively awarded, firm fixed-price delivery order has an ultimate completion date of July 22, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with the Defense Logistics Agency (DLA) Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $3,967.00 to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Xcopri 100 mg tablets (30-count units). This is a firm fixed price delivery order with a completion date of October 28, 2025, and represents a competitively awarded, non-set-aside contract. The award is performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,362.91 on December 11, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026....